R6 Ballot (1st Draft)

This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions

Example MedicinalProductDefinition/example (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition.

Generated Narrative

Id: example

Identifier: {mpid}

Classification: ATC: B01AF02

Attached Document: (SmPC)

Master File: (Pharmacovigilence Master File)

Product Name: Equilidem 2.5 mg film-coated tablets

Name Part

part:Equilidem

type: Invented

Name Part

part:2.5 mg

type: Strength

Name Part

part:film-coated tablets

type: Form

Country & Languages

- Country Jurisdiction Language
* EU EU EN

Manufacturing & Business Operations

- Type EffectiveDate Authorization
* Batch Release 2013-03-15 --> (ongoing) 1324TZ

 

Other examples that reference this example:

  • ClinicalUseDefinition/General
  • ClinicalUseDefinition/General
  • ClinicalUseDefinition/General
  • ClinicalUseDefinition/General
  • ClinicalUseDefinition/General
  • ClinicalUseDefinition/General

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.